Linkedin Share
News

Incredible New Cancer Treatment Uses Modified Herpes to 'Blow Up' Tumors

Linkedin Share

Cancer truly is one of the great medical scourges of our lifetimes, if not the most menacing outright. There are nary an American who has not been affected by the illness in one way or another, which it be a personal fight with The Big C or the struggles and losses that loved ones have experienced.

But now, thanks to a somewhat unconventional new treatment, there appears to be some serious hope on the horizon for cancer patients, and it utilizes a rather common virus.

A new cancer therapy that uses a modified herpes virus to attack tumor cells showed promise in early clinical trials abroad.

The drug, called RP2, completely obliterated one patient’s oral cancer. The 39-year-old told the BBC that he had cancer of the salivary glands, which continued to grow despite attempts at treatment.

He was preparing for the end of his life when he learned about the experimental drug, which was available through a phase one safety trial at the Institute of Cancer Research in the UK.

Trending:
Massive Migrant Caravan Marches Toward US with LGBT Flags Flying as Mexican President Snubs Biden at Summit

After a short course of the drug, the patient — Krzysztof Wojkowski of west London — has been cancer-free for two years and counting, he told the BBC.

The herpes simplex virus has a rather sordid reputation due to its ability to be transmitted as an STD, but is also responsible for cold sores.  There is also evidence that a version of the virus is responsible for Bell’s Palsy.

The method of the virus’ success is wild.

The experimental therapy involves a weakened form of herpes simplex — the virus that causes cold sores — that has been modified to only infect tumors.

According to results presented at a medical conference in Paris, the viral therapy is engineered to selectively enter cancer cells while leaving normal cells alone. It’s injected directly into a tumor, while most other cancer drugs work systemically.

Once it has infiltrated, the virus replicates itself until the cancer cell explodes. What’s unique about RP2 is that it delivers a “one-two punch” against tumors, not only destroying the cells but rallying the immune system to attack what’s left, lead researcher Kevin Harrington said in a news release.

And while this experimental treatment is still not ready for mass consumption, it does provide hope that humanity may soon be able to conquer cancer and improve the quality of life of a vast number of people.

Submit a Correction →



Linkedin Share
About the Author:
As a lifelong advocate for the dream promised us in the Constitution, Andrew West has spent his years authoring lush prose editorial dirges regarding America's fall from grace and her path back to prosperity. When West isn't railing against the offensive whims of the mainstream media or the ideological cruelty that is so rampant in the US, he spends his time seeking adventurous new food and fermented beverages, with the occasional round of golf peppered in.




Conversation